Long-Term Follow-Up Outcome of Imatinib Mesylate Treatment for Recurrent and Unresectable Gastrointestinal Stromal Tumors

Digestion 2013;87:47–52 (DOI:10.1159/000343938)
Source: Karger Publishers - Category: Cancer & Oncology Source Type: research